Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2016
17th World Conference on Lung Cancer
Access to all presentations that occur during the 17th World Conference on Lung Cancer in Vienna, Austria
Presentation Date(s):- Dec 4 - 7, 2016
- Total Presentations: 2466
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
OA03 - Immunotherapy Checkpoint Inhibitors in Advanced NSCLC
- Type: Oral Session
- Track: Chemotherapy/Targeted Therapy/Immunotherapy
- Presentations: 8
- Moderators:L. Crinò
- Coordinates: 12/05/2016, 11:00 - 12:30, Hall C8
-
+
OA03.01 - First-Line Nivolumab Monotherapy and Nivolumab plus Ipilimumab in Patients with Advanced NSCLC: Long-Term Outcomes from CheckMate 012 (Abstract under Embargo until December 5, 7:00 CET)
11:00 - 11:10 | Author(s): S.N. Gettinger
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
ISS07 - Industry Supported Symposium: Immuno-Oncology and Lung Cancer: Emerging Data and Recent Developments - Bristol-Myers Squibb
- Type: Industry Supported Symposium
- Track:
- Presentations: 6
- Moderators:M.D. Hellmann
- Coordinates: 12/05/2016, 12:45 - 14:15, Hall D (Plenary Hall)
-
+
ISS07.01 - Welcome & Introduction
12:45 - 12:55 | Author(s): M.D. Hellmann
- Abstract
No abstract available for this presentation
-
+
ISS07.02 - Developments in the Use of I-O Monotherapy in Lung Cancers
12:55 - 13:10 | Author(s): E. Felip
- Abstract
No abstract available for this presentation
-
+
ISS07.03 - Rationale for Studying I-O Combo Therapies to Address Unmet Needs in Lung Cancer
13:10 - 13:35 | Author(s): M.D. Hellmann
- Abstract
No abstract available for this presentation
-
+
ISS07.04 - Clinical Lessons Learned for the Use of I-O Therapies
13:35 - 13:55 | Author(s): J. Wolf
- Abstract
No abstract available for this presentation
-
+
ISS07.05 - Close & Outlook
13:55 - 14:00 | Author(s): M.D. Hellmann
- Abstract
No abstract available for this presentation
-
+
ISS07.06 - Audience Q&A
14:00 - 14:15
- Abstract
No abstract available for this presentation
-
+
MA09 - Immunotherapy Combinations
- Type: Mini Oral Session
- Track: Chemotherapy/Targeted Therapy/Immunotherapy
- Presentations: 12
- Moderators:M. Sebastian
- Coordinates: 12/06/2016, 14:20 - 15:50, Strauss 2
-
+
MA09.05 - Nivolumab Alone or with Ipilimumab in Recurrent Small Cell Lung Cancer (SCLC): 2-Year Survival and Updated Analyses from the Checkmate 032 Trial
14:50 - 14:56 | Author(s): M.D. Hellmann
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
OA20 - Immunotherapy and Markers
- Type: Oral Session
- Track: Biology/Pathology
- Presentations: 8
- Moderators:M. Früh
- Coordinates: 12/07/2016, 11:00 - 12:30, Stolz 2
-
+
OA20.01 - Tumor Mutation Burden (TMB) is Associated with Improved Efficacy of Atezolizumab in 1L and 2L+ NSCLC Patients
11:00 - 11:10 | Author(s): M. Kowanetz
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
